Patent · US Active

Acyl sulfonamides for treating cancer

US12357603B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignees

BAYER HEALTHCARE LLC · DE
The Broad Institute, Inc. · US

Inventors

Lea Aurelie BOUCHE · Basel, CH
Daniel Korr · Berlin, DE
Antonius Ter Laak · Berlin, DE
Ernesto Amaury Fernandez-Montalvan · Le Pecq, FR
Naomi Barak · Berlin, DE
Roman Hillig · Berlin, DE
Roland Neuhaus · Berlin, DE
Matyas Gorjanacz · Berlin, DE
Vera Pütter · Berlin, DE
Stefan N. Gradl · San Diego, US
Simon Anthony HERBERT · Berlin, DE
Steven James Ferrara · Cambridge, US
Craig Strathdee · Watertown, US
Jacob Jaffe · Cambridge, US

Key dates

Filing date	Apr 20, 2020
Grant date	Jul 15, 2025
Priority date	—
Expiry date	Sep 24, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides acyl sulfonamide compounds of general formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.